{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:43:33Z","timestamp":1788263013995,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-No. 2014K1A4A7A01074644"],"award-info":[{"award-number":["NRF-No. 2014K1A4A7A01074644"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004083","name":"Korean government (MSIP)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institut Pasteur Korea, part of the Institut Pasteur International Network (RIIP)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.antiviral.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T17:07:59Z","timestamp":1467652079000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner"],"prefix":"10.1016","volume":"132","author":[{"given":"Myungeun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-8059","authenticated-orcid":false,"given":"Sanghyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2233-9449","authenticated-orcid":false,"given":"Yong-Soo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.07.002_bib1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gutjnl-2012-304299","article-title":"Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells","volume":"63","author":"Anggakusuma","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2016.07.002_bib2","doi-asserted-by":"crossref","first-page":"e1001086","DOI":"10.1371\/journal.ppat.1001086","article-title":"A\u00a0novel small molecule inhibitor of hepatitis C virus entry","volume":"6","author":"Baldick","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.antiviral.2016.07.002_bib3","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/AAC.02083-13","article-title":"A\u00a0small-molecule inhibitor of hepatitis C virus infectivity","volume":"58","author":"Bush","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.002_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"Calland","year":"2012","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.antiviral.2016.07.002_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/156652412798376152","article-title":"HCV infection by cell-to-cell transmission: choice or necessity?","volume":"12","author":"Carloni","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.antiviral.2016.07.002_bib8","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AEM.66.6.2378-2384.2000","article-title":"The macrocyclic peptide antibiotic micrococcin P(1) is secreted by the food-borne bacterium Staphylococcus equorum WS 2733 and inhibits Listeria monocytogenes on soft cheese","volume":"66","author":"Carnio","year":"2000","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.antiviral.2016.07.002_bib9","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1046\/j.0014-2956.2001.02591.x","article-title":"Pyridinyl polythiazole class peptide antibiotic micrococcin P1, secreted by foodborne Staphylococcus equorum WS2733, is biosynthesized nonribosomally","volume":"268","author":"Carnio","year":"2001","journal-title":"Eur. J. Biochemistry\/FEBS"},{"key":"10.1016\/j.antiviral.2016.07.002_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2016.07.002_bib11","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry","volume":"54","author":"Ciesek","year":"2011","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.antiviral.2016.07.002_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1039\/b919071f","article-title":"Micrococcin P1: structure, biology and synthesis","volume":"27","author":"Ciufolini","year":"2010","journal-title":"Nat. Product. Rep."},{"key":"10.1016\/j.antiviral.2016.07.002_bib13","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0402253101","article-title":"CD81 is an entry coreceptor for hepatitis C virus","volume":"101","author":"Cormier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.07.002_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.26733","article-title":"Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry","volume":"59","author":"Douam","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.antiviral.2016.07.002_bib15","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A\u00a0third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.07.002_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.21774","article-title":"Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C","volume":"46","author":"Forestier","year":"2007","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.antiviral.2016.07.002_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1208953","article-title":"Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C","volume":"368","author":"Gane","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.07.002_bib19","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.00049-11","article-title":"Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A","volume":"85","author":"Gottwein","year":"2011","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.gastro.2012.03.036","article-title":"A\u00a0plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes","volume":"143","author":"Haid","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2016.07.002_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/md12010317","article-title":"Thiopeptide antibiotics: retrospective and recent advances","volume":"12","author":"Just-Baringo","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.antiviral.2016.07.002_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/viro.2001.0903","article-title":"Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells","volume":"284","author":"Kalajzic","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.07.002_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/JVI.01134-06","article-title":"Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I","volume":"81","author":"Kapadia","year":"2007","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2016.01.010","article-title":"Benzothiazepinecarboxamides: novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions","volume":"129","author":"Kim","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.07.002_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2013.04.020","article-title":"Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals","volume":"99","author":"Kim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.07.002_bib26","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/AAC.00054-12","article-title":"Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus","volume":"56","author":"Lam","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.002_bib27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Sci. New York N.Y."},{"key":"10.1016\/j.antiviral.2016.07.002_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Sci. New York N.Y."},{"key":"10.1016\/j.antiviral.2016.07.002_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/0-387-25515-X_2","article-title":"Long alkylchain iminosugars block the HCV p7 ion channel","volume":"564","author":"Pavlovic","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2016.07.002_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.07.002_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A\u00a0three-dimensional model to analyze drug-drug interactions","volume":"14","author":"Prichard","year":"1990","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.07.002_bib32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.42.3.715","article-title":"The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite","volume":"42","author":"Rogers","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.002_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/nar\/22.3.357","article-title":"The antibiotics micrococcin and thiostrepton interact directly with 23S rRNA nucleotides 1067A and 1095A","volume":"22","author":"Rosendahl","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.07.002_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"Sainz","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.07.002_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pauz.201090122","article-title":"BMS-790 052-an oral antiviral hepatitis C antiviral in the pipeline","volume":"40","author":"Schmitz","year":"2011","journal-title":"Pharmazie unserer Zeit"},{"key":"10.1016\/j.antiviral.2016.07.002_bib36","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a beta-d-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.07.002_bib37","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.00118-08","article-title":"Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles","volume":"82","author":"Steinmann","year":"2008","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.antiviral.2016.07.002_bib39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","article-title":"Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry","volume":"80","author":"Tscherne","year":"2006","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib40","doi-asserted-by":"crossref","first-page":"29889","DOI":"10.1074\/jbc.270.50.29889","article-title":"A\u00a0base substitution within the GTPase-associated domain of mammalian 28 S ribosomal RNA causes high thiostrepton accessibility","volume":"270","author":"Uchiumi","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.002_bib41","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/jmv.20947","article-title":"Molecular and cellular determinants of cell-to-cell transmission of HCV in\u00a0vitro","volume":"79","author":"Valli","year":"2007","journal-title":"J.\u00a0Med. Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib42","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/JVI.02534-12","article-title":"Low oxygen tension enhances hepatitis C virus replication","volume":"87","author":"Vassilaki","year":"2013","journal-title":"J.\u00a0Virol"},{"key":"10.1016\/j.antiviral.2016.07.002_bib43","first-page":"487","article-title":"The role of resistance in HCV treatment. Best practice & research","volume":"26","author":"Vermehren","year":"2012","journal-title":"Clin. Gastroenterol."},{"key":"10.1016\/j.antiviral.2016.07.002_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.07.002_bib45","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in\u00a0vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T09:04:58Z","timestamp":1600851898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216302017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":45,"alternative-id":["S0166354216302017"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}